Key highlights from the ESMO Targeted Anticancer Therapies Asia Congress 2025

IF 28.5 1区医学 Q1 ONCOLOGY

Nature cancer Pub Date : 2025-09-12 DOI:10.1038/s43018-025-01046-6

Vincenzo Giacco

引用次数: 0

Abstract

The ESMO Targeted Anticancer Therapies Asia Congress took place in Hong Kong from 18–20 July 2025. Focusing on innovation, early clinical trials, and regulatory insights, the meeting advanced key discussions shaping the future of cancer research and treatment in the region.

查看原文本刊更多论文

ESMO靶向抗癌治疗2025亚洲大会的主要亮点。

ESMO靶向抗癌治疗亚洲大会于2025年7月18日至20日在香港举行。会议聚焦于创新、早期临床试验和监管见解，推进了塑造该地区癌症研究和治疗未来的关键讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature cancer Medicine-Oncology

CiteScore

31.10

自引率

1.80%

发文量

129

期刊介绍： Cancer is a devastating disease responsible for millions of deaths worldwide. However, many of these deaths could be prevented with improved prevention and treatment strategies. To achieve this, it is crucial to focus on accurate diagnosis, effective treatment methods, and understanding the socioeconomic factors that influence cancer rates. Nature Cancer aims to serve as a unique platform for sharing the latest advancements in cancer research across various scientific fields, encompassing life sciences, physical sciences, applied sciences, and social sciences. The journal is particularly interested in fundamental research that enhances our understanding of tumor development and progression, as well as research that translates this knowledge into clinical applications through innovative diagnostic and therapeutic approaches. Additionally, Nature Cancer welcomes clinical studies that inform cancer diagnosis, treatment, and prevention, along with contributions exploring the societal impact of cancer on a global scale. In addition to publishing original research, Nature Cancer will feature Comments, Reviews, News & Views, Features, and Correspondence that hold significant value for the diverse field of cancer research.